Reply to the Letter to the Editor: Can Nutritional and Inflammatory Markers Be Combined to Develop an Accurate Survival Model for Surgical Decision-making in Patients With Lung Cancer Bone Metastases?
사설/논평
0/5 보강
APA
Yan Y, Zhang Y (2026). Reply to the Letter to the Editor: Can Nutritional and Inflammatory Markers Be Combined to Develop an Accurate Survival Model for Surgical Decision-making in Patients With Lung Cancer Bone Metastases?. Clinical orthopaedics and related research, 484(4), 823-825. https://doi.org/10.1097/CORR.0000000000003875
MLA
Yan Y, et al.. "Reply to the Letter to the Editor: Can Nutritional and Inflammatory Markers Be Combined to Develop an Accurate Survival Model for Surgical Decision-making in Patients With Lung Cancer Bone Metastases?." Clinical orthopaedics and related research, vol. 484, no. 4, 2026, pp. 823-825.
PMID
41769862
같은 제1저자의 인용 많은 논문 (5)
- CRYβB2 is a biomarker for poor prognosis and response to CDK4/6 inhibitors in breast cancer.
- A novel mouse cell line model reveals the tumor intrinsic and immune characteristics of EGFR-mutant lung cancer.
- Predictive Value of Age-Adjusted Charlson Comorbidity Index on Survival Outcomes of Hepatocellular Carcinoma Patients with Comorbidities Undergoing Radiofrequency Ablation.
- Proteogenomic features define subtypes of mantle cell lymphoma.
- Arenobufagin suppresses lung cancer cell growth by disrupting mitochondrial function and inducing relocalization of ATP synthase.